BMY - Bristol-Myers Squibb Company

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue20,776,00019,427,00016,560,00015,879,000
Cost of Revenue5,917,0004,925,0003,825,0003,781,000
Gross Profit14,859,00014,502,00012,735,00012,098,000
Operating Expenses
Research Development4,823,0004,405,0004,037,0003,913,000
Selling General and Administrative4,686,0004,911,0004,831,0004,717,000
Non Recurring----
Others----
Total Operating Expenses15,426,00014,241,00012,693,00012,411,000
Operating Income or Loss5,350,0005,186,0003,867,0003,468,000
Income from Continuing Operations
Total Other Income/Expenses Net-219,000729,000-1,790,000-1,087,000
Earnings Before Interest and Taxes5,350,0005,186,0003,867,0003,468,000
Interest Expense-196,000-167,000-184,000-203,000
Income Before Tax5,131,0005,915,0002,077,0002,381,000
Income Tax Expense4,156,0001,408,000446,000352,000
Minority Interest106,000170,000158,000131,000
Net Income From Continuing Ops975,0004,507,0001,631,0002,029,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income1,007,0004,457,0001,565,0002,004,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares1,007,0004,457,0001,565,0002,004,000